AMPH
Amphastar Pharmaceuticals Inc

1,125
Mkt Cap
$1.41B
Volume
15.00
52W High
$45.39
52W Low
$20.39
PE Ratio
11.37
AMPH Fundamentals
Price
$25.65
Prev Close
$26.01
Open
$25.97
50D MA
$25.58
Beta
0.71
Avg. Volume
476,118.42
EPS (Annual)
$3.06
P/B
1.53
Rev/Employee
$360,930.47
Loading...
Loading...
News
all
press releases
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Barclays
Barclays initiated coverage on Amphastar Pharmaceuticals in a research note on Tuesday. They set an "equal weight" rating and a $30.00 target price for the company...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Barclays
Barclays initiated coverage on Amphastar Pharmaceuticals in a research note on Tuesday. They set an "equal weight" rating and a $30.00 target price for the company...
MarketBeat·23h ago
News Placeholder
Marshall Wace LLP Sells 183,037 Shares of Amphastar Pharmaceuticals, Inc. $AMPH
Marshall Wace LLP decreased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 17.7% in the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·1d ago
News Placeholder
Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Quantbot Technologies LP
Quantbot Technologies LP increased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 188.8% during the second quarter, according to the company in its most recent 13F...
MarketBeat·2d ago
News Placeholder
Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Quantbot Technologies LP
Quantbot Technologies LP increased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 188.8% during the second quarter, according to the company in its most recent 13F...
MarketBeat·2d ago
News Placeholder
American Century Companies Inc. Sells 74,832 Shares of Amphastar Pharmaceuticals, Inc. $AMPH
American Century Companies Inc. trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 24.3% in the second quarter, according to its most recent filing with the...
MarketBeat·2d ago
News Placeholder
American Century Companies Inc. Sells 74,832 Shares of Amphastar Pharmaceuticals, Inc. $AMPH
American Century Companies Inc. trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 24.3% in the second quarter, according to its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
CRMD's lead product, DefenCath, generates $167.6M in sales in the first nine months of 2025, with market exclusivity through 2033 likely to provide growth momentum.
Zacks·5d ago
News Placeholder
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
CRMD's lead product, DefenCath, generates $167.6M in sales in the first nine months of 2025, with market exclusivity through 2033 likely to provide growth momentum.
Zacks·5d ago
News Placeholder
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
CRMD's lead product, DefenCath, generates $167.6M in sales in the first nine months of 2025, with market exclusivity through 2033 likely to provide growth momentum.
Zacks·5d ago

Latest AMPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.